Lamya Hamad
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 2
- Colorectal Cancer Treatments and Studies 2
- Cancer-related Molecular Pathways 1
- Co-authors
- Marc S. Ernstoff (2 shared papers)Chong Wang (2 shared papers)Shipra Gandhi (1 shared paper)Elizabeth Repasky (1 shared paper)Manu Raj Pandey (1 shared paper)Mark J. Bucsek (1 shared paper)Kristopher M. Attwood (2 shared papers)Yara George Abdou (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)Journal of Oncology Practice (1 paper)Diabetes Research and Clinical Practice (1 paper)Medicine (1 paper)Immunotherapy (1 paper)
- Partner nations
- United States
In The Last Decade
Lamya Hamad
9 papers receiving 2.3k citations
Lamya Hamad's Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 1.7k
- Immunology 315
- Genetics 138
- Pulmonary and Respiratory Medicine 389
- Hepatology 55
Countries citing papers authored by Lamya Hamad
This map shows the geographic impact of Lamya Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamya Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamya Hamad more than expected).
Fields of papers citing papers by Lamya Hamad
This network shows the impact of papers produced by Lamya Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamya Hamad. The network helps show where Lamya Hamad may publish in the future.
Co-authors
The 14 scholars most cited alongside Lamya Hamad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group Hit paper breakdown → | 2017 | 1589 |
| 2 | Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events Hit paper breakdown → | 2021 | 652 |
| 3 | 2019 | 36 | |
| 4 | 2020 | 28 | |
| 5 | 2023 | 12 | |
| 6 | 2019 | 11 | |
| 7 | 2016 | 9 | |
| 8 | 2016 | 5 | |
| 9 | 2024 | 1 |
About Lamya Hamad
Lamya Hamad is a scholar working on Oncology, Emergency Medical Services, Nephrology, Cancer Research and Psychiatry and Mental health, having authored 9 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Dialysis and Renal Disease Management (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper), Cancer-related Molecular Pathways (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (1.7k citations), Immunology (315 citations), Genetics (138 citations), Pulmonary and Respiratory Medicine (389 citations) and Hepatology (55 citations). Lamya Hamad has collaborated with scholars based in United States. Frequent co-authors include Marc S. Ernstoff, Chong Wang, Shipra Gandhi, Elizabeth Repasky, Manu Raj Pandey, Mark J. Bucsek, Kristopher M. Attwood, Yara George Abdou, Ankita Rungta Kapoor and Kilian Elizabeth Salerno. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Journal of Oncology Practice, Diabetes Research and Clinical Practice, Medicine and Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.